Back to top
Top
U.S. flag

An official website of the United States government

Proportion measure

Year CMS eCQM ID Measure Name
2023 CMS130v11 Colorectal Cancer Screening
2024 CMS130v12 Colorectal Cancer Screening
2025 CMS130v13 Colorectal Cancer Screening
2023 CMS131v11 Diabetes: Eye Exam
2024 CMS131v12 Diabetes: Eye Exam
2025 CMS131v13 Diabetes: Eye Exam
2023 CMS133v11 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2024 CMS133v12 Cataracts: 20 over 40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2025 CMS133v13 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2023 CMS135v11 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 CMS135v12 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 CMS135v13 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 CMS136v12 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2024 CMS136v13 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2025 CMS136v14 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2023 CMS137v11 Initiation and Engagement of Substance Use Disorder Treatment
2024 CMS137v12 Initiation and Engagement of Substance Use Disorder Treatment
2025 CMS137v13 Initiation and Engagement of Substance Use Disorder Treatment
2023 CMS138v11 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2024 CMS138v12 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention